American Journal of Cardiology
Volume 103, Issue 6 , Pages 887-890, 15 March 2009

Effects of Testosterone on Ventricular Repolarization in Hypogonadic Men

  • Beny Charbit, MD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Corresponding Author InformationCorresponding author: Tel: 33-1-49-28-24-04; fax: 33-1-49-28-21-08
  • ,
  • Sophie Christin-Maître, MD, PhD

      Affiliations

    • Department of Pharmacology, Université Pierre et Marie Curie Paris 06, Paris, France
    • Department of Endocrinology, Université Pierre et Marie Curie Paris 06, Paris, France
  • ,
  • Jean-Louis Démolis, MD, PhD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
  • ,
  • Elsa Soustre, PharmD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
  • ,
  • Jacques Young, MD, PhD

      Affiliations

    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
  • ,
  • Christian Funck-Brentano, MD, PhD

      Affiliations

    • Institut National de la Santé et de la Recherche Médicale (INSERM), CIC-9304, Paris, France
    • Department of Pharmacology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France
    • Department of Endocrinology, Assistance Publique - Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France

Received 18 August 2008; received in revised form 20 November 2008; accepted 20 November 2008. published online 27 January 2009.

QT-interval duration is shorter in men than in women. Estrogens do not significantly influence the duration of repolarization. The effect of testosterone has not been studied directly in humans. The aim of this study was to assess the effects of testosterone on corrected QT duration in hypogonadic men. Eleven hypogonadic men were enrolled in this prospective interventional study. Digital electrocardiograms were recorded for each participant at 3 levels of testosterone, high, medium, and low, after a single intramuscular administration of testosterone. Heart rate–independent assessment of QT-interval duration was used. QT1,000 (QT at 60 beats/min) was determined for each subject. Total blood testosterone and the ratio of testosterone to sex hormone–binding globulin were assessed at each visit. The median values of QT1,000 were 352 ms (interquartile range 340 to 363), 357 ms (interquartile range 349 to 367), and 363 ms (interquartile range 357 to 384) at high, medium, and low testosterone concentrations, respectively (p <0.013 for the 3 comparisons). A maximal mean difference of 13.6 ± 2.8 ms (p = 0.0007) was observed between high and low levels of testosterone. A negative linear relation was found between QT1,000 and testosterone concentration (p = 0.0001) or the ratio of testosterone to sex hormone–binding globulin (p = 0.004). In conclusion, the difference in QT-interval duration between men and women might be explained by differences in testosterone levels, and testosterone shortens ventricular repolarization.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a grant-in-aid from INSERM and Assistance Publique - Hôpitaux de Paris at the Clinical Investigation Center of Hôpital Saint-Antoine, Paris, France. The legal sponsor was INSERM (RBM 04-06).

PII: S0002-9149(08)02114-0

doi:10.1016/j.amjcard.2008.11.041

American Journal of Cardiology
Volume 103, Issue 6 , Pages 887-890, 15 March 2009